Liu, M., Bender, S. A., Cuny, G. D., Sherman, W., Glicksman, M., & Ray, S. S. (2013). Type II Kinase Inhibitors Show an Unexpected Inhibition Mode against Parkinson’s Disease-Linked LRRK2 Mutant G2019S.

Liu, Min, Samantha A. Bender, Gregory D. Cuny, Woody Sherman, Marcie Glicksman, and Soumya S. Ray. Type II Kinase Inhibitors Show an Unexpected Inhibition Mode against Parkinson’s Disease-Linked LRRK2 Mutant G2019S. 2013.

Liu, Min, et al. Type II Kinase Inhibitors Show an Unexpected Inhibition Mode against Parkinson’s Disease-Linked LRRK2 Mutant G2019S. 2013.